API Goserelin CAS 65807-02-5

Description:

Goserelin in hominibus adhibetur ut cancer prostatae tractarent.In mulieribus adhibetur carcinomata quaedam mammarum tractare vel inordinationem quandam uteri (endometriosis).Usus est etiam in feminis ad tunicam uteri tenuandam in praeparatione ad procedendum ad sanguinem uteri abnormis tractandum.

Contactus: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

Whatsapp: LXXXVI CLXXXVI 2503 (LX)XLIII (WeChat & Telegram & Line)

Skype: slhyzy

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio

Specification

Product Name	Goserelin
Nomen chemicum	PYR-HIS-TRP-SER-TYR-D-SER(TBU)LEU-ARG-PRO AZAGLY-NH2 ACETATE SALIO
Alia Nomen	GOSERELINACETATESALT;(D-SER(TBU)6,AZAGLY10)-GONADOTROPIN-RELEASINGHORMONEACETATESALT;(D-SER(TBU)6,AZAGLY10)-LHRHACETATESALT; -SER(TBU)6,AZAGLY10)-LUTEINIZINGHORMONE-RELEASINGHORMONEACETATESALT;2-(aminocarbonyl)hydrazide;decapeptidei
CAS Number	65807-02-5
Formulae hypotheticae	C59H84N18O14
Formula Pondus	1269.41
Aspectus	Pulvis albus
Assay	99.0% min
Density	1.50±0.1 g/cm3
sarcina	pera, uter, orum, or as you required
Repono	Repone continens arcte clausus in loco sicco & frigido.Non exponere solis dirigere.
COA & MSDS	Praesto
Applicationem	Ad investigationes propositum

Consuetudinem

Goserelin parenteraliter administratur, gonadotropinum hormonum solvens (GnRH) agonist quod inhibitionem productionis estrogeni et androgeni affert et praevalens adhibetur ad cancer prostatae tractandae.